Novartis 3Q Kisqali Sales Rise 37% to $1.82B
Novartis reported third-quarter Kisqali sales of $1.82 billion, up 37% at constant currency.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.